Global Expansion Excelya operates in 28 countries across Europe, the USA, and India, indicating significant international reach and an opportunity to leverage its global footprint for expanding services into emerging markets.

Therapeutic Focus Specializing in oncology, rare diseases, infectious diseases, and immunotherapy, Excelya presents opportunities to provide tailored clinical trial solutions to biotech and pharma companies targeting high-growth therapeutic areas.

Recognition and Sustainability Winning the EcoVadis Silver Medal highlights Excelya's commitment to sustainability, making it an attractive partner for organizations prioritizing green and socially responsible practices in their supply chain.

Technological Capabilities Using a diverse tech stack including Cloudera, Ennov, and Google Analytics, Excelya can benefit from advanced data management and analytics solutions, opening cross-sell opportunities to enhance trial efficiency and data insights.

Market Position With revenue between $100M and $250M and a dedicated team of over 900 experts, Excelya is positioned as a mid-sized yet rapidly growing CRO, offering potential for strategic partnerships to accelerate its service offerings and geographic reach.